NeoCol trial: Neoadjuvant chemotherapy does not improve disease-free survival in patients with locally advanced colon cancer
1. Neoadjuvant capecitabine-oxaliplatin chemotherapy did not improve three-year disease-free survival compared to upfront surgery in locally advanced colon cancer. 2....